//= $dist_path ?> //= $dist_path ?> //= $dist_path ?>
Around 3.2 million individuals worldwide suffer from renal failure. With innovative products and therapies we define highest standards for the dialysis treatment of patients with chronic kidney failure and and extracorporeal therapies for organ support.
Our Global Research & Development (GRD) activities enable us to develop products efficiently and to systematically promote the exchange of knowledge and technology between regions. Our intention to develop innovative products that are not only of the highest quality, but are also affordable so that caregivers and patients can benefit from them.
Our R & D strategy is focused on improving our ability to deliver innovative competitive products on time and enhancing our focus on developing countries. We have identified six core areas as the future focal points of our R & D activities.
We need entrepreneurs and explorers, people who are passionate about the opportunity to make a difference in the life of our patients.
Our global approach enables us to respond to the demand for improved high-quality yet effordable treatment methods, which is growing worldwide. In doing so, we continue to take regional market conditions into account by offering products in 120 countries.
Do you want to get information about GRD at first hand? Then get in contact with colleagues from GRD directly. Click on the button to send an e-mail with your question to our Fresenius Ambassadors.